The Congressional Budget Office told lawmakers in December 2024 that not extending the enhanced subsidies would cause 2.2 ...

Vicks took the top spot ahead of Rinvoq, Skyrizi and Tremfya, which continue to be the top spenders on national TV pharma ads.

It sounds like something from a science fiction novel, but Alabama officials’ plan to use robots to improve care for rural pregnant women and their babies is real.

Vaccine skeptics push to remove medical mandates at state level; The rollout of TrumpRx; Leadership chaos reigns at HHS, CDC.

​​For FY2026, Dentsu is guiding for another year of modest top‑line expansion and disciplined margins. It forecasts group ...

The need for personalized, relevant engagement at the individual HCP level has never been greater — but to truly drive impact it must align with system priorities. In this session, Precision at Scale: ...

Labcorp has hired Racquel White as its chief communications officer.

Back in October, Havas raised its full-year guidance for 2025 on the back of a strong third-quarter net-revenue gain of 3.8% on an organic basis, to €656 million ($688.8 million). It said then that it ...

One year after taking charge of the nation’s health department, Health and Human Services Secretary Robert F. Kennedy Jr. hasn’t held true to many of the promises he made while appealing to U.S.

Bella Czajkowski most recently served as newsletter editor for Essen Health Care as well as metro stringer for The New York Times.

Only one spot — Novo Nordisk’s for Wegovy — touts a branded pharmaceutical drug. Two of the five encourage screenings for ...

Novo takes aim at Hims & Hers over compounded version of Wegovy pill; The flaw with TrumpRx; Vertex Pharmaceuticals’ CRISPR ...